Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Genentech plans phase III studies of second-generation t-PA

May 7, 1997

Positive clinical results for desirudin in the prevention of thromboembolism

May 5, 1997

Vascular Therapeutics reports positive safety and efficacy profile for Vasoflux

April 28, 1997

Orally active antiplatelet agents disclosed by Mitsui Toatsu

April 22, 1997

Stable prostacyclins disclosed by Asahi Glass

April 21, 1997

Factor Xa inhibitors from Boehringer Mannheim

April 18, 1997

New fibrinogen antagonist from DuPont Merck

April 17, 1997

DuPont Merck presents new thrombin inhibitor

April 17, 1997

Novel aggregation pathway identified

April 16, 1997

Roberts' Agrylin available today in U.S.

April 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...